BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 16540033)

  • 1. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
    Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
    Climent V; Marín F; Mainar L; Roldán V; García A; Martínez JG; Lip GY
    Int J Cardiol; 2009 Feb; 132(2):227-32. PubMed ID: 18234374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
    Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
    Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
    J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Janion M
    Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.